Log In
Wednesday 21st March 2018

Kidney risk link to drug combo

8th February 2008

Researchers in the UK have said use of the clotting drug aprotinin in combination with angiotensin-converting enzyme (ACE) inhibitors during cardiac operations leads to a danger of kidney problems.

Researchers from the department of anesthesia, at Bristol Royal Infirmary, looked at data from 9,875 cardiac surgery patients. Aprotinin was linked with double the risk of renal dysfunction in those patients who also received ACE inhibitors. The study was published in The Lancet this week.

Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018